Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HENRY RODRIGUEZ

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1962434662
CMS profile
179371
Location
TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$81,147.34

58 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
SANOFI-AVENTIS U.S. LLC $77,874.44 51
Merck Sharp & Dohme LLC $1,395.00 1
Mannkind Corporation $1,317.50 2
Sequel Med Tech, LLC $155.96 1
BETA BIONICS, INC. $144.72 1
Neurocrine BioSciences, Inc. $133.88 1
Tandem Diabetes Care, Inc. $125.84 1

Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HENRY RODRIGUEZ

NPI 1962434662 · CMS profile ID 179371

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Endocrinology

TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962434662?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962434662?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962434662?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1962434662?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

58 matching records · $81,147.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 58 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 58.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sequel Med Tech, LLC $155.9611/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243750180 CMS
Mannkind Corporation $42.5010/09/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1250882274 CMS
SANOFI-AVENTIS U.S. LLC $142.0009/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698735 CMS
SANOFI-AVENTIS U.S. LLC $5,152.5009/30/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1233698737 CMS
SANOFI-AVENTIS U.S. LLC $128.6609/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698739 CMS
Neurocrine BioSciences, Inc. $133.8809/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242963817 CMS
SANOFI-AVENTIS U.S. LLC $3,870.0009/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698723 CMS
SANOFI-AVENTIS U.S. LLC $52.9209/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698725 CMS
SANOFI-AVENTIS U.S. LLC $118.3008/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698705 CMS
SANOFI-AVENTIS U.S. LLC $3,225.0008/27/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698707 CMS
SANOFI-AVENTIS U.S. LLC $25.2008/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698709 CMS
SANOFI-AVENTIS U.S. LLC $7,740.0007/29/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698697 CMS
SANOFI-AVENTIS U.S. LLC $476.3707/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698699 CMS
SANOFI-AVENTIS U.S. LLC $2,902.5007/29/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698713 CMS
SANOFI-AVENTIS U.S. LLC $328.8307/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698715 CMS
SANOFI-AVENTIS U.S. LLC $30.6507/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698717 CMS
SANOFI-AVENTIS U.S. LLC $44.0007/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698719 CMS
SANOFI-AVENTIS U.S. LLC $123.1107/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698721 CMS
SANOFI-AVENTIS U.S. LLC $1,935.0007/22/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698691 CMS
Mannkind Corporation $1,275.0007/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1250882272 CMS
Tandem Diabetes Care, Inc. $125.8405/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241281271 CMS
SANOFI-AVENTIS U.S. LLC $121.8304/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698675 CMS
SANOFI-AVENTIS U.S. LLC $7,740.0004/30/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698677 CMS
SANOFI-AVENTIS U.S. LLC $170.0904/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698679 CMS
SANOFI-AVENTIS U.S. LLC $352.1804/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698681 CMS
SANOFI-AVENTIS U.S. LLC $188.4004/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698683 CMS
SANOFI-AVENTIS U.S. LLC $71.8104/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698685 CMS
SANOFI-AVENTIS U.S. LLC $655.6104/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698687 CMS
SANOFI-AVENTIS U.S. LLC $149.9804/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698663 CMS
SANOFI-AVENTIS U.S. LLC $3,708.0004/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698695 CMS
SANOFI-AVENTIS U.S. LLC $116.9803/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698655 CMS
SANOFI-AVENTIS U.S. LLC $3,547.5003/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698657 CMS
SANOFI-AVENTIS U.S. LLC $25.2003/13/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698659 CMS
SANOFI-AVENTIS U.S. LLC $2,257.5003/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698661 CMS
SANOFI-AVENTIS U.S. LLC $120.1803/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698665 CMS
SANOFI-AVENTIS U.S. LLC $3,547.5003/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698667 CMS
SANOFI-AVENTIS U.S. LLC $25.2003/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698669 CMS
SANOFI-AVENTIS U.S. LLC $7,740.0003/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698731 CMS
SANOFI-AVENTIS U.S. LLC $63.5703/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698741 CMS
SANOFI-AVENTIS U.S. LLC $70.4803/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698743 CMS
SANOFI-AVENTIS U.S. LLC $362.5603/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698745 CMS
SANOFI-AVENTIS U.S. LLC $586.7203/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698747 CMS
SANOFI-AVENTIS U.S. LLC $426.3603/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698749 CMS
SANOFI-AVENTIS U.S. LLC $8,062.5002/14/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698641 CMS
SANOFI-AVENTIS U.S. LLC $445.3502/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698643 CMS
SANOFI-AVENTIS U.S. LLC $770.3402/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698645 CMS
SANOFI-AVENTIS U.S. LLC $123.4802/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698647 CMS
SANOFI-AVENTIS U.S. LLC $22.0002/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698649 CMS
SANOFI-AVENTIS U.S. LLC $57.9002/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698651 CMS
BETA BIONICS, INC. $144.7202/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246807341 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,245.98 23
PY2020 $4,037.50 3
PY2021 $10,500.00 5
PY2022 $2,550.00 2
PY2023 $28,773.62 31
PY2024 $78,819.50 50
PY2025 $81,147.34 58

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,132.10 8
PY2025 Principal investigator $23,837.57 17
PY2024 Principal investigator $38,121.96 130
PY2023 Recipient $31,152.69 10
PY2023 Principal investigator $334,432.51 152
PY2022 Principal investigator $280,252.64 210
PY2021 Recipient $106.13 2
PY2021 Principal investigator $321,118.06 433
PY2020 Recipient $2,040.00 1
PY2020 Principal investigator $354,412.20 52
PY2019 Principal investigator $133,599.16 29

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Dexcom, Inc. $1,000.00 12/02/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962376
Principal investigator 1 Dexcom, Inc. $1,521.00 12/02/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962378
Principal investigator 1 Novo Nordisk AS $399.99 11/20/2025 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1213741470
Principal investigator 1 Novo Nordisk AS $728.00 11/20/2025 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1213820883
Principal investigator 1 SANOFI US SERVICES INC. $1,500.00 11/20/2025 Non-covered Recipient Entity
University Of South Florida
A Real-World Observational Study Characterizing Patients With Type 1 Diabetes Treated with Teplizumab (TEPLI-REAL) No dispute reported 06/30/2026 1226085739
Principal investigator 1 SANOFI US SERVICES INC. $1,800.00 11/20/2025 Non-covered Recipient Entity
University Of South Florida
A Real-World Observational Study Characterizing Patients With Type 1 Diabetes Treated with Teplizumab (TEPLI-REAL) No dispute reported 06/30/2026 1226085743
Principal investigator 1 Dexcom, Inc. $4.50 10/21/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962374
Principal investigator 1 SANOFI US SERVICES INC. $1,200.00 10/02/2025 Non-covered Recipient Entity
University Of South Florida
A Real-World Observational Study Characterizing Patients With Type 1 Diabetes Treated with Teplizumab (TEPLI-REAL) No dispute reported 06/30/2026 1226085747
Principal investigator 1 Novo Nordisk AS $1,799.98 07/16/2025 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1213744379
Recipient SANOFI US SERVICES INC. $77.55 07/03/2025 Covered Recipient Physician A randomized, double-blind, 2-arm, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with newly diagnosed Stage 3 Type 1 Diabetes (T1D) No dispute reported 06/30/2026 1226150737
Recipient SANOFI US SERVICES INC. $20.63 07/03/2025 Covered Recipient Physician A randomized, double-blind, 2-arm, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with newly diagnosed Stage 3 Type 1 Diabetes (T1D) No dispute reported 06/30/2026 1226150742
Principal investigator 1 Dexcom, Inc. $500.00 06/24/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962372
Recipient SANOFI US SERVICES INC. $402.06 06/19/2025 Covered Recipient Physician A randomized, double-blind, 2-arm, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with newly diagnosed Stage 3 Type 1 Diabetes (T1D) No dispute reported 06/30/2026 1226150702
Recipient SANOFI US SERVICES INC. $187.24 06/19/2025 Covered Recipient Physician A randomized, double-blind, 2-arm, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with newly diagnosed Stage 3 Type 1 Diabetes (T1D) No dispute reported 06/30/2026 1226150716
Recipient SANOFI US SERVICES INC. $153.48 06/19/2025 Covered Recipient Physician A randomized, double-blind, 2-arm, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with newly diagnosed Stage 3 Type 1 Diabetes (T1D) No dispute reported 06/30/2026 1226150721
Recipient SANOFI US SERVICES INC. $201.26 06/18/2025 Covered Recipient Physician A randomized, double-blind, 2-arm, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with newly diagnosed Stage 3 Type 1 Diabetes (T1D) No dispute reported 06/30/2026 1226150708
Recipient SANOFI US SERVICES INC. $85.00 06/18/2025 Covered Recipient Physician A randomized, double-blind, 2-arm, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with newly diagnosed Stage 3 Type 1 Diabetes (T1D) No dispute reported 06/30/2026 1226150729
Recipient SANOFI US SERVICES INC. $4.88 06/18/2025 Covered Recipient Physician A randomized, double-blind, 2-arm, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with newly diagnosed Stage 3 Type 1 Diabetes (T1D) No dispute reported 06/30/2026 1226150751
Principal investigator 1 Dexcom, Inc. $482.00 05/20/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962368
Principal investigator 1 Dexcom, Inc. $723.00 04/08/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962370
Principal investigator 1 Dexcom, Inc. $482.00 03/18/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962362
Principal investigator 1 Dexcom, Inc. $4,668.10 03/04/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962366
Principal investigator 1 Novo Nordisk AS $364.00 01/31/2025 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1213826727
Principal investigator 1 Dexcom, Inc. $4,850.00 01/07/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962360
Principal investigator 1 Dexcom, Inc. $1,815.00 01/07/2025 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250962364